Medical Properties Trust

Shares of Medical Properties Trust hit a new 52-week low of $3.99 and remain under sustained pressure; they are down 15.9% year-to-date and 21.7% over six months. The company completed a private placement and an exchange transaction that issued $2.4 billion of senior secured notes (maturing 2032) and refinanced about $1.5 billion of unsecured notes with maturities from 2027–2031. In the second quarter, revenue of $259.28 million beat expectations but showed a small loss of $0.01 per share; normalized FFO were $0.15 per share. Management reports progress on its refinancing plan to eliminate debt maturities through 2027; market capitalization is $2.39 billion with a dividend yield of 8.89%, and analysts see a possible return to profitability. » More on de.investing.com

Medical Properties Trust issued, in a private placement, $2.4 billion in senior secured notes due February 15, 2032, with a 9.25% coupon. Proceeds will be used to fully repay 2026 maturities and to partially redeem 2027 notes; in addition, about $1.5 billion of unsecured bonds were refinanced in a private exchange. The notes are secured by first- and second‑priority liens and guarantees, include covenants and change-of-control repurchase options; the transaction covers roughly 25% of the company’s total debt. » More on de.investing.com

Medical Properties Trust reported Q2 2026 revenue of $259.28 million (expectation $248.01 million) with reported GAAP EPS of -$0.01 (expectation $0.0047). Normalized FFO was $0.15, up from the prior quarter and in line with expectations. The stock fell about 12.45% in premarket trading to $4.115 as investors weighed the missed GAAP EPS, payment delinquencies at operators such as HSA, and execution risks of the balance-sheet strategy. Management announced a refinancing to extend maturities totaling $2.4 billion through 2032 and planned asset sales of up to $1.1 billion to bolster liquidity. » More on de.investing.com